Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.013
-0.097 (-4.62%)
Oct 8, 2026, 11:39 AM EDT - Market open
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $1.6 million as of October 8, 2026. It is the 48,459th most valuable company in the world and the 6,572nd biggest in the United States. Its market cap has decreased by 42.37% in one year.
Market Cap
1.60M
Enterprise Value
-4.50M
1-Year Change
-42.37%
Global Rank
Country Rank
#6,572 United States
Category
ChartMarket Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $1.60M, a decrease of -99.23%. That is a compound annual growth rate of -68.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.60M | -37.52% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onconetix | 2.36M |
| Silo Pharma | 2.29M |
| Oragenics | 2.26M |
| Genprex | 2.15M |
| Alaunos Therapeutics | 2.13M |
| Lakewood-Amedex Biotherapeutics | 2.01M |
| Valion Bio | 1.94M |
| Artelo Biosciences | 1.87M |